-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Evome Medical Technologies Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2021 to Q1 2022.
- Evome Medical Technologies Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending February 28, 2022 was CA$4.48M, a 54.3% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (CAD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)